Entheon Biomedical | Company Summary | CNSX:ENBI ISIN:CA29383X1116 | Canadian National Stock Exchange ABN Newswire

News
Join Ellis Martin for a conversation with Timothy Ko, the CEO of Entheon Biomedical (CNSX:ENBI) (OTCMKTS:ENTBF). Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.Read Full Article▸
Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction-recovery ratio, turning the 'untreatable case' and 'lost cause' from the norm to the exception.Read Full Article▸

Related Keywords

United States ,Canada , ,European Union ,Entheon Biomedical ,Cnsx Enbi ,Canadian National Stock Exchange ,Isin Ca29383x1116 ,Drugs Otc ,Pharmaceutical ,ஒன்றுபட்டது மாநிலங்களில் ,கனடா ,ஐரோப்பிய தொழிற்சங்கம் ,கனடியன் தேசிய ஸ்டாக் பரிமாற்றம் ,மருந்துகள் ஆரீட ,மருந்து ,